T/CAB 0431-2025 Active Group standards

T/CAB 0431-2025 Data-driven technical specifications for AI-driven full-process drug development

Publish Date: 2025-10-13 Implement Date: 2025-10-13 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CAB 0431-2025

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Comprehensive Pharmaceutical Science

Publish Date: 2025-10-13

Implement Date: 2025-10-13

Scope

This document stipulates the technical requirements for data collection and integration, data analysis and modeling, model validation and evaluation, and data management and security throughout the entire process of AI drug R&D, as well as supporting supervision and evaluation mechanisms. This document clarifies the core requirements and operational norms for the application of artificial intelligence (AI) technology in the data-driven phase of the entire drug R&D process, and is applicable to scientific research institutions, pharmaceutical companies, technology service providers, and other entities involved in AI drug R&D activities. It covers key stages from the initial target discovery phase of drug R&D to molecular design (including molecular generation and optimization), virtual screening, preclinical research, and data processing and model application in clinical trials.